Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent representations he has made to representatives of the Medicines and Healthcare products Regulatory Agency (MHRA) on accelerating the approval of Trodelyn for treating metastatic triple negative breast cancer (TNBC).

No such representations have been made. The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for independently assessing the efficacy and safety of drugs before approval.